Results 171 to 180 of about 22,257 (214)
Effects on Serum Protein Levels From One Bout of High Intensity Interval Training in Individuals With Axial Spondyloarthritis and Controls. [PDF]
Immun Inflamm DisAndersson Å +4 more
europepmc +1 more source
Beyond inflammation: the molecular basis of bone remodeling in axial spondyloarthritis and psoriatic arthritis. [PDF]
Front ImmunolLopalco G +5 more
europepmc +1 more source
Topography of entheseal lesions on ultrasound: a comparative study between axial spondyloarthritis, psoriatic arthritis and healthy controls. [PDF]
RMD OpenElsehrawy GG +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Lancet
Axial spondyloarthritis manifests as a chronic inflammatory disease primarily affecting the sacroiliac joints and spine. Although chronic back pain and spinal stiffness are typical initial symptoms, peripheral (ie, enthesitis, arthritis, and dactylitis) and extra-musculoskeletal (ie, uveitis, inflammatory bowel disease, and psoriasis) manifestations ...
Victoria Navarro-Compán +3 more
+9 more sources
Axial spondyloarthritis manifests as a chronic inflammatory disease primarily affecting the sacroiliac joints and spine. Although chronic back pain and spinal stiffness are typical initial symptoms, peripheral (ie, enthesitis, arthritis, and dactylitis) and extra-musculoskeletal (ie, uveitis, inflammatory bowel disease, and psoriasis) manifestations ...
Victoria Navarro-Compán +3 more
+9 more sources
The Lancet, 2013
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease predominantly of the sacroiliac joint (SIJ) and the spine. It starts normally in the second decade of life and has a slight male predominance. The prevalence is between 0.2% and 0.8% and is strongly dependent on the prevalence of HLA-B27 in a given population.
Joachim, Sieper, Denis, Poddubnyy
openaire +2 more sources
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease predominantly of the sacroiliac joint (SIJ) and the spine. It starts normally in the second decade of life and has a slight male predominance. The prevalence is between 0.2% and 0.8% and is strongly dependent on the prevalence of HLA-B27 in a given population.
Joachim, Sieper, Denis, Poddubnyy
openaire +2 more sources
Nonradiographic axial spondyloarthritis
Best Practice & Research Clinical Rheumatology, 2017Non-radiographic axial spondyloarthritis (nr-axSpA) is a complex disease process that is part of the spectrum of axial spondyloarthritis (axSpA). This article reviews the current state of the literature as the understanding of this disease spectrum expands. The conceptual history and terminology, genetics, and epidemiology are reviewed.
Megan M, Lockwood, Lianne S, Gensler
openaire +2 more sources
2023
Abstract Spondyloarthritis (SpA) is a blanket term encompassing a family of chronic inflammatory joint diseases that commonly involve the SI joints, spine, and the limbs, and share many clinical features, including frequent association with inflammation affecting the eyes, the gut, and the skin.
Xenofon Baraliakos +2 more
openaire +2 more sources
Abstract Spondyloarthritis (SpA) is a blanket term encompassing a family of chronic inflammatory joint diseases that commonly involve the SI joints, spine, and the limbs, and share many clinical features, including frequent association with inflammation affecting the eyes, the gut, and the skin.
Xenofon Baraliakos +2 more
openaire +2 more sources
Axial Spondyloarthritis in Japan
Current Rheumatology Reports, 2022The differences in the epidemiology and management of patients with axial spondyloarthritis (axSpA) among regions and countries largely depend on the positivity of human leukocyte antigen (HLA)-B27 and the health care system. This review article focused on axSpA in Japan, where the prevalence of HLA-B27 is extremely low (0.3%) and the universal health ...
Hideto Kameda +5 more
openaire +2 more sources
Novel therapies in axial spondyloarthritis
Best Practice & Research Clinical Rheumatology, 2022Over the past two decades, advancements in understanding the pathogenesis of axial spondyloarthritis have led to discoveries of new therapeutic targets, particularly the interleukin-17, tumor necrosis factor axis, and Janus kinase-signal transducer and activator of transcription pathway.
Mohamad, Bittar, Philip, Mease
openaire +2 more sources